Smart Contact Lens Keeps an Eye on Your Eyes—Even When They’re Closed | Newswise

Smart Contact Lens Keeps an Eye on Your Eyes—Even When They’re Closed | Newswise

Newswise — Vision disorders impact over a billion people worldwide, with glaucoma being one of the most insidious due to its slow, symptomless progression. Key biomarkers like elevated IOP and irregular eye movement (EM) often go unnoticed, especially during sleep, when traditional open-eye instruments fall short. Nocturnal like intraocular pressure (IOP) spikes and rapid eye…

Read More
Cedars-Sinai Health Sciences University Celebrates First Graduates | Newswise

Cedars-Sinai Health Sciences University Celebrates First Graduates | Newswise

LOS ANGELES (June 20, 2025) — They will always be the first. Newswise — The class of 2025 of Cedars-Sinai Health Sciences University are the trailblazing biomedical students who made Cedars-Sinai history earlier this month when they became the university’s inaugural graduates.   At the 13th Commencement Ceremony, the university’s Graduate School of Biomedical Sciences awarded 24 degrees—four doctorates…

Read More
RWJBarnabas Health, Rutgers Cancer Institute, Tufts Medical Center, and The University of Manchester Develop First Risk Prediction Model for Early-Stage Classic Hodgkin’s Lymphoma | Newswise

RWJBarnabas Health, Rutgers Cancer Institute, Tufts Medical Center, and The University of Manchester Develop First Risk Prediction Model for Early-Stage Classic Hodgkin’s Lymphoma | Newswise

Newswise — New Brunswick, N.J. and Boston, M.A., June 19, 2025 – Researchers from RWJBarnabas Health and Rutgers Cancer Institute, New Jersey’s only National Cancer Institute-designated Comprehensive Cancer Center, as well as Tufts Medical Center and The University of Manchester have developed and validated the first individualized risk prediction model for adults diagnosed with early-stage…

Read More
Imunoterapia potencializa quimioterapia no combate ao câncer colorretal em estágio 3 | Newswise

Imunoterapia potencializa quimioterapia no combate ao câncer colorretal em estágio 3 | Newswise

Newswise — ROCHESTER, Minnesota — O câncer colorretal é o terceiro tipo mais comum no mundo. Embora o exame preventivo tenha ajudado a detectar e prevenir a disseminação do câncer colorretal, os principais avanços em seu tratamento parecem lentos. Agora, uma nova pesquisa realizada pelo Mayo Clinic Comprehensive Cancer Center (Centro de Câncer da Mayo…

Read More
“Digital Tumors” for Precision Oncology: UC San Diego Receives Award from ARPA-H | Newswise

“Digital Tumors” for Precision Oncology: UC San Diego Receives Award from ARPA-H | Newswise

Newswise — Researchers at University of California San Diego have been awarded a contract of up to $23.6 million from the Advanced Research Projects Agency for Health (ARPA-H) within the U.S. Department of Health and Human Services (HHS) to develop and validate a new approach for selecting treatments for cancer. The six-year project, titled “Dynamic Digital…

Read More
Gene Expression After Asbestos Exposure Explains Development of Malignant Mesothelioma | Newswise

Gene Expression After Asbestos Exposure Explains Development of Malignant Mesothelioma | Newswise

Philadelphia, PA — Gene expression leading to alterations in the DNA caused by asbestos exposure may explain the development of Malignant Pleural Mesothelioma (MPM), a rare and aggressive cancer. By analyzing public RNA-seq data through a comprehensive bioinformatics pipeline, scientists working with the Sbarro Health Research Organization (SHRO) have developed an in-depth view of the…

Read More
Considering Cases with Rheumatic Reactions to Cancer Immunotherapy | Newswise

Considering Cases with Rheumatic Reactions to Cancer Immunotherapy | Newswise

Newswise — Philadelphia, PA  — The prevalence and severity of rheumatic adverse reactions in cancer immunotherapy is significantly underestimated, due to the lack of standardized screening protocols for malignancies in patients with autoimmune disorders. In response to the need for data collection and diagnostic criteria, researchers have developed a trans-disciplinary approach to safeguard those patients…

Read More
A Machine Learning Tool for Diagnosing, Monitoring Colorectal Cancer | Newswise

A Machine Learning Tool for Diagnosing, Monitoring Colorectal Cancer | Newswise

Newswise — COLUMBUS, Ohio – Scientists aiming to advance cancer diagnostics have developed a machine learning tool that is able to identify metabolism-related molecular profile differences between patients with colorectal cancer and healthy people.  The analysis of biological samples from more than 1,000 people also revealed metabolic shifts associated with changing disease severity and with…

Read More